← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-35 | Methadone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-501 | 81375-501-01 | Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:913 | 913 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:913 | 913 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:913 | 913 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:913 | 913 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:914 | 914 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7427 | 72934-7427-6 | Chlohux | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:914 | 914 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-2 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:914 | 914 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Hyaluronidase | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1118 | 5446-1118-01 | Lidocaine; Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:914 | 914 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-30 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-05 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8613 | 71266-8613-1 | Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:914 | 914 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-348 | 83298-348-09 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:914 | 914 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-13 | Oxycodone Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:915 | 915 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | ESTRADIOL 12.5 PEL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:915 | 915 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1502 | 73271-1502-1 | Lidocaine Hydrochloride; Medroxyprogesterone Acetate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0790 | 5446-0790-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:915 | 915 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Cyanocobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-1 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2041 | 71286-2041-2 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-133 | 70092-133-43 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-03 | Methadone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5066 | 26436-5066-3 | Niacinamide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:915 | 915 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:915 | 915 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-25 | Oxycodone Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:916 | 916 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5484 | 26436-5484-2 | ABI | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:916 | 916 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:916 | 916 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:916 | 916 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0407 | 5446-0407-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:916 | 916 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Cyanocobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-519 | 70092-519-48 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-125 | 70092-125-48 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:916 | 916 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:916 | 916 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2547 | 72934-2547-2 | Niacinamide; Azelaic Acid | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-117 | 69194-117-10 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:916 | 916 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:917 | 917 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-02 | Methadone HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:917 | 917 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:917 | 917 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0408 | 5446-0408-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:917 | 917 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:917 | 917 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-521 | 70092-521-74 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1075 | 71266-1075-1 | Methylprednisolone Acetate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:917 | 917 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2529 | 72934-2529-2 | Niacinamide; Calcipotriene | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:917 | 917 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:917 | 917 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:918 | 918 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-104 | 69194-104-10 | 104 DILTIAZEM HCL 125MG/125ML | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:918 | 918 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-09 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:918 | 918 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1018 | 5446-1018-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:918 | 918 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:918 | 918 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-380 | 70092-380-36 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1010 | 73013-1010-1 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-2632 | 26436-2632-3 | Methionine; Inositol; Choline Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:918 | 918 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3563 | 72934-3563-8 | Niacinamide; Clindamycin Phosphate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:918 | 918 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5103 | 71266-5103-1 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:919 | 919 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-164 | 63037-164-25 | Lidocaine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:919 | 919 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-05 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:919 | 919 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3552 | 73271-3552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0850 | 5446-0850-10 | Lidocaine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-518 | 70092-518-75 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:919 | 919 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Choline Chloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:919 | 919 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:919 | 919 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2617 | 72934-2617-8 | Niacinamide; Clobetasol Propionate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:919 | 919 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:919 | 919 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:920 | 920 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0021 | 70168-0021-1 | Testo25mgCHOL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:920 | 920 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:920 | 920 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1552 | 73271-1552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:920 | 920 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-07 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-16 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5595 | 26436-5595-3 | Methionine; Inositol; Choline Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:920 | 920 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:920 | 920 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2586 | 72934-2586-2 | Niacinamide; Dapsone | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:920 | 920 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:921 | 921 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-004 | 73217-004-10 | Tacrolimus 0.5% Ophth | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:921 | 921 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:921 | 921 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:921 | 921 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8114 | 73271-8114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:921 | 921 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:921 | 921 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-01 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-04 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-01 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5594 | 26436-5594-3 | Methionine; Inositol; Choline Chloride; Cyanocobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-585 | 69194-585-01 | Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5066 | 26436-5066-3 | Niacinamide | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2615 | 72934-2615-2 | Niacinamide; Fluocinolone Acetonide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:921 | 921 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:921 | 921 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0903 | 83863-0903-1 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:922 | 922 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1594 | 72934-1594-2 | Kazuri | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:922 | 922 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:922 | 922 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:922 | 922 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4552 | 73271-4552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:922 | 922 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:922 | 922 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-50 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-02 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-28 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5030 | 26436-5030-3 | Methionine; Inositol; Choline Chloride; Cyanocobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2414 | 72934-2414-2 | Niacinamide; Azelaic Acid | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1533 | 72934-1533-2 | Niacinamide; Ivermectin; Metronidazole | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:922 | 922 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-348 | 83298-348-10 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:922 | 922 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:923 | 923 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0006 | 71285-0006-1 | Reperfusate 4 to1 NO K 477.5ml Bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:923 | 923 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:923 | 923 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:923 | 923 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2114 | 73271-2114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:923 | 923 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6795 | 60652-6795-2 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-128 | 70092-128-50 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-25 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-259 | 81375-259-05 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2395 | 72934-2395-2 | Niacinamide; Calcipotriene | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:923 | 923 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1532 | 72934-1532-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:923 | 923 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:923 | 923 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:924 | 924 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-020 | 73198-020-10 | QM-4 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:924 | 924 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:924 | 924 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:924 | 924 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2552 | 73271-2552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:924 | 924 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-1 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9004 | 83826-9004-1 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3303 | 72934-3303-3 | Niacinamide; Clindamycin Phosphate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:924 | 924 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2525 | 72934-2525-2 | Niacinamide; Lactic Acid | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:924 | 924 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:924 | 924 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:925 | 925 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | ESTRADIOL 12.5MG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:925 | 925 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:925 | 925 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-5114 | 73271-5114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-2 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:925 | 925 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-3 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-132 | 70092-132-43 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:925 | 925 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2364 | 72934-2364-3 | Niacinamide; Clobetasol Propionate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1595 | 72934-1595-2 | Niacinamide; Levocetirizine Dihydrochloride; Imiquimod | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:925 | 925 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-6 | Nystatin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:925 | 925 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:926 | 926 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-008 | 70713-008-01 | TESTOSTERONE SA2 37.5MG | 2025-2 | valid | 0 | 2026-09-18 |